Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.

Autor: Qualls DA; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Lambert N; Department of Medicine, Baylor College of Medicine, Houston, TX., Caimi PF; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH., Merrill M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Pullarkat P; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Godby RC; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Bond DA; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Wehmeyer GT; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Romancik J; Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA., Amoozgar B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Leslie L; Lymphoma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Crombie JL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Abramson JS; Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA., Khurana A; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Nowakowski GS; Hematology Division, Department of Internal Medicine, Mayo Clinic, Rochester, MN., Maddocks K; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, OH., Rutherford SC; Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Kahl B; Department of Medicine, Washington University School of Medicine, St Louis, MO., Okwali M; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Buege MJ; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Seshan V; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Batlevi CL; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY., Salles G; Lymphoma Service, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Weill Cornell Medical College, New York, NY.

Publikováno v: Blood [Blood] 2023 Dec 28; Vol. 142 (26), pp. 2327-2331.

Confirmation of the utility of the Wells' Score for pulmonary embolism in patients with sickle cell disease.

Autor: May JE; Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA. jemay@uabmc.edu., Lauzon SD; Eli Lilly and Company, Indianapolis, IN, USA., Godby RC; Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA., Kanter J; Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA.

Publikováno v: Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2022 Jul; Vol. 54 (1), pp. 193-196. Date of Electronic Publication: 2022 Apr 19.

Optimizing factor VIII dosing in obese individuals with haemophilia A.

Autor: Godby RC; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Raju D; Cancer Treatment Centers of America, Boca Raton, Florida., Massicano F; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Williams LA; Department of Pathology, Division of Laboratory Medicine, Mayo Clinic, Phoenix, Arizona., Black B; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Dorn D; Cunningham Pathology, Tuscaloosa, Alabama, USA., Marques MB; Department of Pathology, Division of Laboratory Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

Publikováno v: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Oct 01; Vol. 32 (7), pp. 528-530.

Depression among older adults with gastrointestinal malignancies.

Autor: Godby RC; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: rgodby@uabmc.edu., Dai C; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Al-Obaidi M; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA., Giri S; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Young-Smith C; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Kenzik K; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., McDonald AM; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Paluri RK; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Gbolahan OB; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Bhatia S; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA., Williams GR; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; Institute for Cancer Outcomes & Survivorship, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2021 May; Vol. 12 (4), pp. 599-604. Date of Electronic Publication: 2020 Nov 04.

Immunotherapy in Older Adults with Cancer.

Autor: Godby RC; Internal Medicine, University of Alabama at Birmingham, Birmingham, AL, USA., Johnson DB; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN, USA., Williams GR; Division of Hematology/Oncology, Geriatrics, and Palliative Care, Institute of Cancer Outcomes and Survivorship, O'Neal Comprehensive Cancer Center at UAB, University of Alabama at Birmingham, 1600 7th Avenue South, Lowder 500, Birmingham, AL, 35233, USA. grwilliams@uabmc.edu.

Publikováno v: Current oncology reports [Curr Oncol Rep] 2019 May 07; Vol. 21 (7), pp. 56. Date of Electronic Publication: 2019 May 07.